C. Altar, M. Marien, and J. Marshall, Time Course of Adaptations in Dopamine Biosynthesis, Metabolism, and Release Following Nigrostriatal Lesions: Implications for Behavioral Recovery from Brain Injury, Journal of Neurochemistry, vol.5, issue.2, pp.390-399, 1987.
DOI : 10.1007/BF00505651

M. Amalric, C. Baunez, and A. Nieoullon, Does the blockade of excitatory amino acid transmission in the basal ganglia simply reverse reaction time deficits induced by dopamine inactivation?, Behavioural Pharmacology, vol.6, issue.5, pp.508-519, 1995.
DOI : 10.1097/00008877-199508000-00011

M. Aymerich, P. Barroso-chinea, M. Pérez-manso, A. Muñoz-patiño, M. Moreno-igoa et al., Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats, European Journal of Neuroscience, vol.471, issue.8, pp.2099-2108, 2006.
DOI : 10.1111/j.1460-9568.2006.04741.x

M. Bannon, S. Michelhaugh, J. Wang, and P. Sacchetti, The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders, European Neuropsychopharmacology, vol.11, issue.6, pp.449-455, 2001.
DOI : 10.1016/S0924-977X(01)00122-5

P. Barnéoud, M. Mazadier, J. M. Miquet, S. Parmentier, P. Dubédat et al., Neuroprotective effects of riluzole on a model of parkinson's disease in the rat, Neuroscience, vol.74, issue.4, pp.971-983, 1996.
DOI : 10.1016/0306-4522(96)00249-7

A. Benazzouz, C. Gross, J. Feger, T. Boraud, and B. Bioulac, Reversal of rigidity and improvement in motor performance by No claim to original US government works Journal Compilation, International Society for Neurochemistry J. Neurochem, vol.113, pp.1459-1470, 1993.

A. Benazzouz, T. Boraud, P. Dubédat, A. Boireau, J. M. Stutzmann et al., Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study, European Journal of Pharmacology, vol.284, issue.3, pp.299-307, 1995.
DOI : 10.1016/0014-2999(95)00362-O

E. Bezard, T. Boraud, B. Bioulac, and C. Gross, Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental Parkinsonism, Neuroscience, vol.81, issue.2, pp.399-404, 1997.
DOI : 10.1016/S0306-4522(97)00226-1

V. Blanchard, M. Chritin, S. Vyas, M. Savasta, C. Feuerstein et al., Long-Term Induction of Tyrosine Hydroxylase Expression: Compensatory Response to Partial Degeneration of the Dopaminergic Nigrostriatal System in the Rat Brain, Journal of Neurochemistry, vol.64, issue.4, pp.1669-1679, 1995.
DOI : 10.1046/j.1471-4159.1995.64041669.x

A. Boireau, J. M. Miquet, and P. Dubedat, Riluzole and experimental parkinsonism, NeuroReport, vol.5, issue.16, pp.2157-2160, 1994.
DOI : 10.1097/00001756-199410270-00042

S. Boulet, S. Mounayar, and A. Poupard, Behavioral Recovery in MPTP-Treated Monkeys: Neurochemical Mechanisms Studied by Intrastriatal Microdialysis, Journal of Neuroscience, vol.28, issue.38, pp.9575-9584, 2008.
DOI : 10.1523/JNEUROSCI.3465-08.2008
URL : https://hal.archives-ouvertes.fr/inserm-00391442

P. Calabresi, N. Mercuri, G. Sancesario, and G. Bernardi, Electrophysiology of dopamine denervated striatal neurons: implications for Parkinson's disease, Brain, vol.116, pp.433-452, 1993.

P. Calabresi, A. Pisani, N. Mercuri, and G. Bernardi, The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia, Trends in Neurosciences, vol.19, issue.1, pp.19-24, 1996.
DOI : 10.1016/0166-2236(96)81862-5

E. Castaneda, I. Whishaw, and T. Robinson, Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size, J. Neurosci, vol.10, pp.1847-1854, 1990.

C. Cepeda, R. Hurst, and K. Altemus, Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor?deficient mice, J. Neurophysiol, vol.85, pp.659-670, 2001.

H. Chen and S. Lipton, Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism., The Journal of Physiology, vol.499, issue.1, pp.27-46, 1997.
DOI : 10.1113/jphysiol.1997.sp021909

H. Chen, J. Pellegrini, S. Aggarwal, S. Lei, S. Warach et al., Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity, J. Neurosci, vol.12, pp.4427-4436, 1992.

A. Chéramy, R. Romo, G. Godeheu, P. Baruch, and J. Glowinski, In vivo presynaptic control of dopamine release in the cat caudate nucleus???II. Facilitatory or inhibitory influence ofl-glutamate, Neuroscience, vol.19, issue.4, pp.1081-1090, 1986.
DOI : 10.1016/0306-4522(86)90124-7

A. Chéramy, J. Desce, G. Godeheu, and J. Glowinski, Presynaptic control of dopamine synthesis and release by excitatory amino acids in rat striatal synaptosomes, Neurochemistry International, vol.25, issue.2, pp.145-154, 1994.
DOI : 10.1016/0197-0186(94)90033-7

T. Cremers, M. De-vries, K. Huinink, J. Van-loon, M. Hart et al., Quantitative microdialysis using modified ultraslow microdialysis: Direct rapid and reliable determination of free brain concentrations with the MetaQuant technique, Journal of Neuroscience Methods, vol.178, issue.2, pp.249-254, 2009.
DOI : 10.1016/j.jneumeth.2008.12.010

W. Danysz, M. Gossel, W. Zajaczkowski, D. Dill, and G. Quack, Are NMDA antagonistic properties relevant for antiparkinsonianlike activity in rats????Case of amantadine and memantine, Journal of Neural Transmission - Parkinson's Disease and Dementia Section, vol.5, issue.Suppl, pp.155-166, 1994.
DOI : 10.1007/BF02253435

W. Danysz, C. Parsons, J. Kornhuber, W. Schmidt, and G. Quack, Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents ??? preclinical studies, Neuroscience & Biobehavioral Reviews, vol.21, issue.4, pp.455-468, 1997.
DOI : 10.1016/S0149-7634(96)00037-1

C. Dentresangle, L. Cavorsin, M. Savasta, M. Leviel, and V. , Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra, Brain Research, vol.893, issue.1-2, pp.178-185, 2001.
DOI : 10.1016/S0006-8993(00)03311-4

J. M. Desce, G. Godeheu, T. Galli, J. Glowinski, and A. Chéramy, Opposite presynaptic regulations by glutamate through NMDA receptors of dopamine synthesis and release in rat striatal synaptosomes, Brain Research, vol.640, issue.1-2, pp.205-214, 1994.
DOI : 10.1016/0006-8993(94)91874-0

A. Doble, The pharmacology and mechanism of action of riluzole, Neurology, vol.47, issue.Issue 6, Supplement 4, pp.233-241, 1996.
DOI : 10.1212/WNL.47.6_Suppl_4.233S

A. Emmi, H. Rajabi, and J. Stewart, Behavioral and neurochemical recovery from partial 6-Hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP, J. Neurosci, vol.16, pp.5216-5224, 1996.

S. Erdo and M. Schafer, Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate, European Journal of Pharmacology, vol.198, issue.2-3, pp.215-217, 1991.
DOI : 10.1016/0014-2999(91)90625-Z

G. Gianutsos, S. Chute, and J. P. Dunn, Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine, European Journal of Pharmacology, vol.110, issue.3, pp.357-361, 1985.
DOI : 10.1016/0014-2999(85)90564-3

F. Gonon, F. Navarre, and M. Buda, In vivo monitoring of dopamine release in the rat brain with differential normal pulse voltammetry, Analytical Chemistry, vol.56, issue.3, pp.573-575, 1984.
DOI : 10.1021/ac00267a060

A. Grace, Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia, Neuroscience, vol.41, issue.1, pp.1-24, 1991.
DOI : 10.1016/0306-4522(91)90196-U

A. Grace, Physiology of the normal and dopamine-depleted basal ganglia: Insights into levodopa pharmacotherapy, Movement Disorders, vol.5, issue.11, pp.560-569, 2008.
DOI : 10.1002/mds.22020

J. Greenamyre, O. Brien, and C. , N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease, Archives of Neurology, vol.48, issue.9, pp.977-981, 1991.
DOI : 10.1001/archneur.1991.00530210109030

F. Hefti, A. Enz, and E. Melamed, Partial lesions of the nigrostriatal pathway in the rat Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs, Neuropharmacology, vol.24, issue.1, pp.19-23, 1985.
DOI : 10.1016/0028-3908(85)90090-5

J. Hollerman and A. Grace, The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons, Brain Research, vol.533, issue.2, pp.203-212, 1990.
DOI : 10.1016/0006-8993(90)91341-D

K. Johnson and Y. Jeng, -aspartate receptors on nigrostriatal dopaminergic nerve terminals, Canadian Journal of Physiology and Pharmacology, vol.69, issue.10, pp.1416-1421, 1991.
DOI : 10.1139/y91-212
URL : https://hal.archives-ouvertes.fr/jpa-00210025

A. Kashani, C. Betancur, B. Giros, E. Hirsch, E. Mestikawy et al., Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease, Neurobiology of Aging, vol.28, issue.4, pp.568-578, 2006.
DOI : 10.1016/j.neurobiolaging.2006.02.010
URL : https://hal.archives-ouvertes.fr/inserm-00154872

K. Keefe, M. Zigmond, and E. Abercrombie, Extracellular dopamine in striatum: Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input, Neuroscience, vol.47, issue.2, pp.325-332, 1992.
DOI : 10.1016/0306-4522(92)90248-Z

J. Kornhuber, J. Bormann, M. Hubers, K. Rushe, and P. Riederer, Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study, European Journal of Pharmacology: Molecular Pharmacology, vol.206, issue.4, pp.297-300, 1991.
DOI : 10.1016/0922-4106(91)90113-V

M. O. Krebs, J. M. Desce, M. L. Kemel, C. Gauchy, G. Godeheu et al., Glutamatergic Control of Dopamine Release in the Rat Striatum: Evidence for Presynaptic N-Methyl-D-Aspartate Receptors on Dopaminergic Nerve Terminals, Journal of Neurochemistry, vol.195, issue.1, 1991.
DOI : 10.1073/pnas.83.18.7104

K. Lange, J. Kornhuber, and P. Riederer, Dopamine/glutamate interactions in Parkinson's disease, Neuroscience & Biobehavioral Reviews, vol.21, issue.4, pp.393-400, 1997.
DOI : 10.1016/S0149-7634(96)00043-7

V. Leviel, The reverse transport of DA, what physiological significance?, Neurochemistry International, vol.38, issue.2, pp.83-106, 2001.
DOI : 10.1016/S0197-0186(00)00076-0

V. Leviel, A. Gobert, and B. Guibert, Direct observation of dopamine compartmentation in striatal nerve terminal by ???in vivo??? measurement of the specific activity of released dopamine, Brain Research, vol.499, issue.2, pp.205-213, 1989.
DOI : 10.1016/0006-8993(89)90768-3

V. Leviel, A. Gobert, and B. Guibert, The glutamate-mediated release of dopamine in the rat striatum: Further characterization of the dual excitatory-inhibitory function, Neuroscience, vol.39, issue.2, pp.305-312, 1990.
DOI : 10.1016/0306-4522(90)90269-A

N. Lindefors and U. Ungerstedt, Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons, Neuroscience Letters, vol.115, issue.2-3, pp.248-252, 1990.
DOI : 10.1016/0304-3940(90)90463-J

S. Lipton, Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond, Nature Reviews Drug Discovery, vol.566, issue.2, pp.160-170, 2006.
DOI : 10.1038/nrd1958

J. Mantz, A. Chéramy, A. Thierry, J. Glowinski, and J. Desmonts, Anesthetic Properties of Riluzole (54274 RP), a New Inhibitor of Glutamate Neurotransmission, Anesthesiology, vol.76, issue.5, pp.844-848, 1992.
DOI : 10.1097/00000542-199205000-00023

S. Mccallum, N. Parameswaran, X. Perez, S. Bao, J. Mcintosh et al., Compensation in pre-synaptic dopaminergic function following nigrostriatal damage in primates, Journal of Neurochemistry, vol.41, issue.4, pp.960-972, 2006.
DOI : 10.1016/0166-2236(90)90112-N

O. Mortensen and S. Amara, Dynamic regulation of the dopamine transporter, European Journal of Pharmacology, vol.479, issue.1-3, pp.159-170, 2003.
DOI : 10.1016/j.ejphar.2003.08.066

W. Nastuk, P. Su, and P. Doubilet, Anticholinergic and membrane activities of amantadine in neuromuscular transmission, Nature, vol.1, issue.5581, pp.76-79, 1976.
DOI : 10.1038/264076a0

A. Nieoullon, A. Cheramy, and J. Glowinski, Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat, Brain Research, vol.148, issue.1, pp.143-152, 1978.
DOI : 10.1016/0006-8993(78)90384-0

J. Oh, D. Russel, C. Vaughan, and T. Chase, Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration, Brain Research, vol.813, issue.1, pp.150-159, 1998.
DOI : 10.1016/S0006-8993(98)01049-X

V. Olivier, B. Guibert, and V. Leviel, Direct in vivo comparison of two mechanisms releasing dopamine in the rat striatum, Brain Research, vol.695, issue.1, pp.1-9, 1995.
DOI : 10.1016/0006-8993(95)00706-V

V. Olivier, A. Gobert, B. Guibert, and V. Leviel, The in vivo modulation of dopamine synthesis by calcium ions: influences on the calcium independent release, Neurochemistry International, vol.35, issue.6, pp.431-438, 1999.
DOI : 10.1016/S0197-0186(99)00094-7

R. Olson, J. Justice, and . Jr, Quantitative microdialysis under transcient conditions, Anal. Chem, vol.68, pp.1017-1022, 1993.

C. Parsons, R. Gruner, J. Rozenthal, J. Millar, and D. Lodge, Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan), Neuropharmacology, vol.32, issue.12, pp.1337-1350, 1993.
DOI : 10.1016/0028-3908(93)90029-3

C. Parsons, G. Quack, I. Bresink, L. Baran, E. Przegalinski et al., Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo, Neuropharmacology, vol.34, issue.10, pp.1239-1258, 1995.
DOI : 10.1016/0028-3908(95)00092-K

X. Perez, N. Parameswaran, L. Huang, K. O-'leary, and M. Quik, Pre-synaptic dopaminergic compensation after moderate nigrostriatal damage in non-human primates, Journal of Neurochemistry, vol.41, issue.5, pp.1861-1872, 2008.
DOI : 10.1016/S0165-0173(97)00048-9

J. Phillips, H. Lam, L. Ackerson, and N. Maidment, Blockade of mGlur5 glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease, 2006.

D. Raju, T. Ahern, D. Shah, T. Wright, D. Standaert et al., Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism, European Journal of Neuroscience, vol.10, issue.7, pp.1647-1658, 2008.
DOI : 10.1073/pnas.0401764101

M. Richard and J. Bennett, NMDA Receptor Blockade Increases In Vivo Striatal Dopamine Synthesis and Release in Rats and Mice with Incomplete, Dopamine-Depleting, Nigrostriatal Lesions, Journal of Neurochemistry, vol.64, issue.5, pp.2080-2086, 1995.
DOI : 10.1046/j.1471-4159.1995.64052080.x

T. Robinson and I. Whishaw, Normalisation of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra : a microdialysis study in freely moving rats, Brain Res, vol.45, pp.209-224, 1988.

R. Romo, A. Chéramy, G. Godeheu, and J. Glowinski, In vivo presynaptic control of dopamine release in the cat caudate nucleus???III. Further evidence for the implication of corticostriatal glutamatergic neurons, Neuroscience, vol.19, issue.4, pp.1091-1099, 1986.
DOI : 10.1016/0306-4522(86)90125-9

D. Samuel, M. Errami, and A. Nieoullon, H]3-(2-Carboxypiperazin-4-yl)propyl-1-Phosphonic Acid Binding, Journal of Neurochemistry, vol.241, issue.6, pp.1926-1933, 1990.
DOI : 10.1016/0003-2697(71)90291-0

R. S. Schwab, A. England, . Jr, and D. Poskanser, Amantadine in the Treatment of Parkinson's Disease, JAMA: The Journal of the American Medical Association, vol.208, issue.7, pp.1168-1170, 1969.
DOI : 10.1001/jama.1969.03160070046011

P. Sonsalla, W. Nicklas, and R. Heikkila, Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity, Science, vol.243, issue.4889, pp.398-400, 1989.
DOI : 10.1126/science.2563176

M. Stachowiak, R. Keller, E. Stricker, and M. Zigmond, Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage, J. Neurosci, vol.7, pp.1648-1654, 1987.

D. Standaert, C. Testa, G. Rudolph, and Z. Hollingsworth, Inhibition of N-methyl-D-aspartate glutamate receptor sub-unit expression by antisens oligonucleotids reveals their role in striatal motor regulation, J. Pharmacol. Exp. Therap, vol.276, pp.342-352, 1996.

A. Storch, K. Burkhardt, and A. Ludolph, Protective Effects of Riluzole on Dopamine Neurons, Journal of Neurochemistry, vol.14, issue.6, pp.2259-2269, 2000.
DOI : 10.1046/j.1471-4159.2000.0752259.x

K. Tang, M. Low, D. Grandy, and D. Lovinger, Dopamine-dependent synaptic plasticity in striatum during in vivo development, Proc. Natl Acad. Sci. USA 98, pp.1255-1260, 2001.
DOI : 10.1073/pnas.98.3.1255

L. Turski, K. Bressler, K. Rettig, P. Löschmann, and H. Wachtel, Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists, Nature, vol.349, issue.6308, pp.414-418, 1991.
DOI : 10.1038/349414a0

J. Ulas and C. Cotman, Dopaminergic denervation of striatum results in elevated expression of NR2A subunit, Neuroreport, vol.7, pp.1789-1793, 1996.

J. Wang, Presynaptic Glutamate Receptors Modulate Dopamine Release from Striatal Synaptosomes, Journal of Neurochemistry, vol.238, issue.3, pp.819-822, 1991.
DOI : 10.1073/pnas.83.18.7104

U. Wullner, C. Testa, M. Catania, A. Young, and P. J. Jr, Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions, Brain Research, vol.645, issue.1-2, pp.98-102, 1994.
DOI : 10.1016/0006-8993(94)91642-X

R. Yokel, D. Allen, D. Burgio, and P. Mcnamara, Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis, Journal of Pharmacological and Toxicological Methods, vol.27, issue.3, pp.135-142, 1992.
DOI : 10.1016/1056-8719(92)90034-X

M. Zigmond, A. Acheson, M. Stachowiak, and E. Stricker, Neurochemical Compensation After Nigrostriatal Bundle Injury in an Animal Model of Preclinical Parkinsonism, Archives of Neurology, vol.41, issue.8, pp.856-861, 1984.
DOI : 10.1001/archneur.1984.04050190062015

M. Zigmond, E. Abercrombie, T. Berger, A. Grace, and E. Stricker, Compensations after lesions of central dopaminergic neurons: some clinical and basic implications, Trends in Neurosciences, vol.13, issue.7, pp.290-296, 1990.
DOI : 10.1016/0166-2236(90)90112-N